Ginsenoside Rg5
CAS No. 186763-78-0
Ginsenoside Rg5 ( —— )
产品货号. M18157 CAS No. 186763-78-0
Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2260 | 有现货 |
|
10MG | ¥3637 | 有现货 |
|
25MG | ¥5986 | 有现货 |
|
50MG | ¥7995 | 有现货 |
|
100MG | ¥11259 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ginsenoside Rg5
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease.
-
产品描述Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease. Ginsenoside Rg5 suppresses LPS-induced nitric oxide (NO) production and proinflammatory TNF-α secretion. Ginsenoside Rg5 can ameliorate lung inflammation possibly by inhibiting the binding of LPS to toll-like receptor (TLR)-4 on macrophages. Ginsenoside Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature. Ginsenoside Rg5 blocks cell cycle of SK-HEP-1 cells at the Gl/S transition phase by down-regulating cyclin E-dependent kinase activity and that the down-regulation of cyclin E-dependent kinase activity is caused mainly by induced CDK2 inhibitor, p21Cip/WAF1 and decreased levels of cyclin E.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体IGF-1R
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number186763-78-0
-
分子量767.01
-
分子式C42H70O12
-
纯度98%
-
溶解度——
-
SMILESCC(=CCC=C(C)C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Methylarbutin
Methylarbutin is an ice recrystallization inhibitor (IRI).
-
OsMundacetone
OsMundacetone is a natual product isolated from Rhizoma osmundae.